Moderna Inc.
MRNA,
+10.73%
announced Friday afternoon that the latest study of its potential COVID-19 vaccine has begun. The first participants in each age range have been dosed with its vaccin⦠[+623 chars]Source
Moderna Inc.
MRNA,
+10.73%
announced Friday afternoon that the latest study of its potential COVID-19 vaccine has begun. The first participants in each age range have been dosed with its vaccin⦠[+623 chars]Source
